Stage & Theatre
Brucemore Outdoor Children's Theatre PDF Print E-mail
News Releases - Stage & Theatre
Written by Tara Richards   
Tuesday, 28 June 2011 12:04

Brucemore Outdoor Children’s Theatre Presents

Grimm Brothers Fairy Tale Repair Shoppe

Children and families will be enchanted as their favorite fairy tale characters take the stage for the 2011 Brucemore Outdoor Children’s Theatre: Grimm Brothers Fairy Tale Repair Shoppe, July 27 – 30 at 5:30 and 7:30 p.m. From fixing Cinderella’s shattered glass slipper to managing a cranky Sleeping Beauty, participation will be encouraged as Will and Jacob Grimm embark on a mission to mend any fairy tale in need of a happy ending. Brucemore’s natural amphitheatre near the pond will set the stage for this show.  Gates open at 5:00 and 7:00 p.m.

Grimm Brothers Fairy Tale Repair Shoppe is an original play written by brothers Joe Link, Associate Drama Director at Cedar Rapids Jefferson High School, and Mike Link, sales associate for Medline Industries, Inc. in Dubuque.  Joe Link was also the creator of past Brucemore Outdoor Children’s Theatre productions: The Incredible Adventures of Captain Spoon, The Forgetful Pirate (2007), The Princess Who Wouldn’t Wear Pink (2009), and Robin Hood: Wanted (2010).

Children and their adult chaperones are encouraged to bring blankets and lawn chairs (no food or beverage please). On-site parking is available. Tickets are $5 for adults and $3 for children.  Tickets are nonrefundable and may be purchased the night of the performance.  Brucemore Outdoor Children’s Theatre is sponsored by US Bank. For additional information, please visit www.brucemore.org or call (319) 362-7375.

Brucemore, Iowa’s only National Trust Historic Site, is located at 2160 Linden Drive SE, Cedar Rapids, Iowa.

 
CLARKE UNIVERSITY SPRING GRADUATION LIST AND DEAN'S LIST PDF Print E-mail
News Releases - Stage & Theatre
Written by The Link Delivery Service   
Friday, 24 June 2011 12:26
Dubuque, Iowa (June 23, 2011) - Clarke University in Dubuque, Iowa, awarded degrees and honors at its 168th Commencement Ceremony on May 14, 2011.
The following area students were honored at the ceremony:
<FULL NAME> of <HOMETOWN, STATE>: <HONORS 1> with a <DEGREE> degree in <MAJOR 1> and <MAJOR 2 OR SECONDARY EDUCATION IF APPLICABLE>; <HONORS PROGRAM OR VALEDICTORIAN IF APPLICABLE>.
Clarke University is a Catholic, liberal arts and sciences university dedicated to preparing students to make an impact. Known for superb teaching and academics, Clarke offers more than 40 undergraduate liberal arts and pre-professional programs and five graduate degree programs. Founded in 1843 by the Sisters of Charity of the Blessed Virgin Mary, Clarke is located near the Mississippi River in Dubuque, Iowa. Clarke's 55-acre campus is a blend of historic buildings and new, state-of-the-art facilities.

Bettendorf, IA
Andrea Sherrick,  , Master of Science in Nursing, Nursing,  ,  ; Sarah M. Woodham,  , Doctor of Physical Therapy, Physical Therapy,  ,  ;

Davenport, IA
Julie A. Pluemer,  , Master of Science in Nursing, Nursing,  ,  ;

Moline, IL
Kaitlyn L. Tipsword, Magna Cum Laude, Bachelor of Science in Nursing, Nursing,  ,  ;

Dubuque, Iowa (June 23, 2011) - The following area students were named to the Dean's List at Clarke University for the spring 2011 semester. The list recognizes full-time Clarke students who have earned a 3.65 grade point average or above, on a 4.0 scale, with a minimum of 12 graded hours.
<FULL NAME>, of <HOMETOWN, STATE>
Clarke University is a Catholic, liberal arts and sciences university dedicated to preparing students to make an impact. Known for superb teaching and academics, Clarke offers more than 40 undergraduate liberal arts and pre-professional programs and five graduate degree programs. Founded in 1843 by the Sisters of Charity of the Blessed Virgin Mary, Clarke is located near the Mississippi River in Dubuque, Iowa. Clarke's 55-acre campus is a blend of historic buildings and new, state-of-the-art facilities.

HOMETOWN, STATE; NAME;

Davenport, IA
Megan M. Chitty; Kristina M. McKenna; Katelyn M. Shima;

Moline, IL
Kaitlyn L. Tipsword;

 
The Queen of Bingo returns to The Old Creamery Studio Stage July 7 PDF Print E-mail
News Releases - Stage & Theatre
Written by Shelley Klimes   
Wednesday, 22 June 2011 15:50

Amana – It’ s back for those who missed it in 2009 and for those who just want to see it again. Sisters Sis and Babe might not agree on much, but they both know there’ s nothing quite like the thrill of being able to yell BINGO! Join them and share the excitement of a good round or two during The Old Creamery Theatre’ s production of The Queen of Bingo.

Written by Jeanne Michels and Phyllis Murphy, the show opens Thursday, July 7at 3 p.m. on The Old Creamery’ s Studio Stage in Middle Amana. The cast consists of Marquetta Senters of South Amana, Ian Zahren, also of South Amana and Krista Neumann of Iowa City. Directed by Nicholas Hodge, the play runs through July 24. Tickets are $27 for adults and $17.50 for students. Show times are Thursdays and Sundays at 3 p.m. and Fridays and Saturdays at 7:30 p.m.

Although walk-ins are always welcome if seats are still available, reservations are highly recommended.

The Old Creamery Theatre Company is a not-for-profit professional theatre founded in 1971 in Garrison, Iowa. The company is celebrating 40 years of bringing live, professional theatre to the people of Iowa and the Midwest. We thank KGAN and Fox 28, our 2011 season media sponsor.

 
AUCUS, GRASSLEY QUESTION MEDTRONIC ABOUT UNREPORTED SIDE EFFECTS, FINANCIAL TIES TO CLINICAL INVESTIGATORS PDF Print E-mail
News Releases - Stage & Theatre
Written by Grassley Press   
Wednesday, 22 June 2011 15:45

Finance Leaders Begin Investigation Into Medtronic Infuse Trials 

Washington, DCSenate Finance Committee Chairman Max Baucus (D-Mont.) and senior Committee member Chuck Grassley (R-Iowa) asked medical device manufacturer Medtronic on Tuesday to produce documents related to its controversial bone growth product Infuse.  In a letter sent to Medtronic, the Committee raised concerns over recent media reports that indicate medical researchers in charge of Infuse clinical trials may have been aware of and failed to report evidence that the product may cause sterility in men and potentially-harmful bone growth.  The letter also notes many of these investigators had substantial financial ties to the device manufacturer.

“These reports that doctors conducting medical trials while on Medtronic’s payroll may have hidden serious side effects for patients are deeply troubling,” said Senate Finance Committee Chairman Baucus.  “Information is one of the most important tools patients and doctors have when making medical decisions.  Patients have a right to know the risks associated with their treatments, and medical device companies have a duty to disclose this information.  We need to do everything we can to ensure companies aren’t concealing serious medical complications from patients just to increase profits.”

“A patient having surgery has to rely on his doctor’s knowing the risks and benefits of a medical device.  The doctor in turn has to rely on the medical literature.  If the medical literature has been written by those with financial ties to the device maker, the doctor and his patient should know that.  A lack of transparency leaves doctors and patients in the dark on something any of us would want to know before surgery.  It’s alarming to learn after the fact that articles draw conflicting conclusions about a device’s safety and complications.  The lack of disclosure of payments raises questions about the integrity of the conclusions reached, whether integrity was compromised or not,” said senior committee member Grassley.

The full text of Baucus’s and Grassley’s letter to Medtronic appears below:

June 21, 2011

Via Electronic Transmission

Omar Ishrak, Ph.D.

Chairman and Chief Executive Officer

Medtronic, Inc.

710 Medtronic Parkway

Minneapolis, MN 55432

Dear Dr. Ishrak:

The United States Senate Committee on Finance (Committee) has jurisdiction over the Medicare and Medicaid programs.  As Chairman and a senior member of the Committee, we have a special responsibility to the more than 100 million Americans who receive health care under those programs to ensure that beneficiaries receive treatments that are safe and effective.

We are extremely troubled by press reports suggesting that doctors conducting clinical trials examining the safety and effectiveness of Infuse on behalf of Medtronic were aware that Infuse, a treatment commonly used in spinal surgery, may cause medical complications, but failed to report this in the medical literature.  This issue is compounded by the fact that some clinical investigators have substantial financial ties to Medtronic. 

  • Last year, the Milwaukee Journal Sentinel reported that a Medtronic-funded study published in 2004 found that 75% of bone morphogenetic protein 2 (BMP-2) patients experienced ectopic bone growth, where potentially harmful bone growth occurs outside of the fusion area.  The authors, who had financial ties to Medtronic, “concluded that ‘although not desirable,’” the ectopic bone growth “did not appear to have an ill effect on the patients.” However, in a separate 2008 study conducted by physicians without financial ties to Medtronic, “neurological impairment occurred” in five patients who had the same ectopic bone formation.[1]
  • According to the New York Times, a recent study “found that men treated with Infuse developed a condition that causes temporary or permanent sterility at a far higher rate than men who received a bone graft.”  This link to sterility was not reported in the original Medtronic-funded study.[2] In addition, the Milwaukee Sentinel Journal reports that one author of the original study, Thomas A. Zdeblick, an orthopedic surgeon at the University of Wisconsin School of Medicine and Public Health, received “more than $23 million in various royalty payments from Medtronic since 2002.”  In addition, “Zdeblick also is the editor of the journal where two of the Infuse papers that failed to mention the link [to sterility] were published.”[3

We are also concerned that other severe side-effects of Infuse and similar bone-growth products developed by Medtronic may have been unreported or under-reported in clinical literature.  Reports have linked Infuse to potentially fatal swelling in the neck and throat, and radiating leg pain.  Concerns have also been expressed about a potential link to cancer.[4

Given these concerns, please provide the Committee with the following documents:

1.       All documents and communications pertaining to adverse postoperative events and/or medical complications relating to the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) treatments, including but not limited to:

a.       All communications with and regarding medical journals or their representatives pertaining to adverse postoperative events and/or medical complications relating to the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) treatments.

b.      All communications with and regarding clinical investigators who participated in Medtronic sponsored clinical trials pertaining to adverse postoperative events and/or medical complications relating to the use of rhBMP-2 treatments.

c.       All communications with and regarding the Food and Drug Administration (FDA) pertaining to adverse postoperative events and/or medical complications relating to the use of rhBMP-2 treatments. 

d.      All communications and records between and among Medtronic and members of FDA Advisory Boards pertaining to adverse postoperative events and/or medical complications relating to the use of rhBMP-2 treatments. 

e.      All communications and records between and among Medtronic and physician consultants pertaining to adverse postoperative events and/or medical complications relating to the use of rhBMP-2 treatments. 

2.      A detailed account of payments that Medtronic made to all Infuse clinical investigators.  Please include payments to corporate entities in which Medtronic-sponsored Infuse clinical investigators are principals. 

3.       For each individual and organization identified in question number 2 above, please provide the following information for each payment in table format:  

a. Date of payment

b. Payment description (CME, royalty, honorarium, research support, etc.)

c. Amount of payment

d. Year end or year-to-date payment total

In cooperating with the Committee’s review, no documents, records, data, or other information related to these matters, either directly or indirectly, shall be destroyed, modified, removed, or otherwise made inaccessible to the Committee.

We look forward to hearing from you by no later than July 11, 2011. All documents responsive to this request should be sent electronically, on a disc, in searchable PDF format to [staff] and [staff].

If you have any questions, please do not hesitate to contact [staff] with Senator Baucus at (202) 224-4515 or [staff] with Senator Grassley at (202) 224-6522.

Sincerely,

 

Charles E. Grassley                       Max Baucus

Senator                                                Chairman


1 “Complications rise along with off-label use of BMP-2,” Journal Sentinel, August 28, 2010.

2 “New Study Links Spine Product From Medtronic to Risk of Sterility in Men,” New York Times, May 25, 2011. 

3 “Researchers get royalties, papers omit sterility link,” Journal Sentinel, May 25, 2011.

4 “Complications rise along with off-label use of BMP-2,” supra note 1.

   

###

 
The Old Creamery Theatre and Fireside Winery team up for dinner and a show July 23 and 28 PDF Print E-mail
News Releases - Stage & Theatre
Written by Shelley Klimes   
Tuesday, 21 June 2011 12:31

Amana – Dinner and a show, what can be better? Especially if the dinner is a delicious buffet and the show a bittersweet love story performed by The Old Creamery Theatre Company at Fireside Winery, in rural Marengo.

Sounds too good to be true, but come Saturday July 23 at 6:30 pm, Fireside Winery will serve up a dinner buffet complete with assorted salads, shrimp scampi, bacon wrapped pork loin in a plum sauce, garlic mashed potatoes, green beans with almonds and a mixedberry stack for dessert. The menu on Thursday, July 28 will consist of all of the above with chicken pasta carbonara and roast beef replacing shrimp scampi and pork loin as the entrees and mini cheesecakes will be the dessert.

The Old Creamery Theatre will take to the stage at 7:30 p.m. for Love Letters, a love story that traces the lifelong correspondence of Andrew and Melissa, two very different people who care deeply for one another. Their relationship spans decades and comes to life through their letters to one another. Love Letters features Tom Milligan and Deborah Kennedy of The Old Creamery Theatre.

Tickets for dinner and the show are $40 per person and will include a free glass of wine of choice. To purchase tickets and make reservations, call Fireside Winery (319) 662-4222. Tickets are non refundable and the event will be held rain or shine.

Fireside Winery is a locally, family owned winery located in rural Marengo on P Avenue(County Rd V77) between Highway 6 and the I – 80 Williamsburg exit, across the road from the Conroy First Lutheran Church. Complete directions can be found on the website at www.firesidewinery.com
The Old Creamery Theatre Company is a not-for-profit professional theatre founded in 1971 in Garrison, Iowa. The company is celebrating 40 years of bringing live, professional theatre to the people of Iowa and the Midwest.

 
<< Start < Prev 131 132 133 134 135 136 137 138 139 140 Next > End >>

Page 135 of 144